Implementation and Effectiveness of the BJC-Pink and Pearl Project on Lung Cancer Screening
Part of paid clinical trials in Creve Coeur, Missouri.
- Sponsor
- Washington University School of Medicine
- Study ID
- NCT06898333
- Status
- Recruiting
Conditions
- Cancer of the Lung
- Lung Cancer
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Study Details
The investigators proposal is ripe for executing as the investigators seek to leverage this "natural experiment" initiated by the BJC health system to evaluate the effectiveness of the Pink \& Pearl Campaign as an implementation strategy to promote lung cancer screening (LCS) uptake among LCS-eligible women undergoing mammography at BJC West County. This evaluation is grounded in the Integrated Screening Action Model that depicts individual- and environmental-level influences on the screening behavior process. Using an explanatory sequential mixed methods design, which combines both quantitative and qualitative approaches, the research questions and specific aims for this proposal are to: a) evaluate the baseline prevalence of LCS among LCS-eligible women; b) assess whether the Pink \& Pearl Campaign increases referrals and uptake/ completion of LCS among LCS-eligible women undergoing screening mammography; and c) evaluate individual and environmental factors influencing LCS uptake, and implementation outcomes of the campaign. These implementation outcomes will help identify whether the campaign was put in place successfully or not. This proposal will inform strategies for integrating cancer screening programs to improve poorly performing programs like LCS.
Key Dates
- Start date
- May 8, 2025
- Status verified
- May 2026
- Primary completion
- Nov 30, 2026
- Completion
- May 31, 2027
Study Design
- Enrollment
- 279 participants (estimated)
Arms
- Arm: Participants - scheduled for mammography and eligible for LCSWomen who are scheduled for mammography and are potentially LCS-eligible will be approached by the registration team and will complete a survey. Subjects who were referred for LCS will be contacted and the investigators will gauge their interest in returning for dual breast and lung screening program in future and rate their experience on a patient satisfaction scale.
- Arm: ProvidersProviders in the breast radiology service who referred women to LCS. Investigators will gather information on the feasibility, acceptability, and appropriateness of the Pink and Pearl project.
Primary Outcome Measure
Prevalence of LCS-eligible women who opt-in to, and successfully, complete LCS mammography and opt-in to lung cancer screening [ Time Frame: At baseline ]
Central Contacts
- Beryne Odeny, M.D., MPH, Ph.D.314-362-1183
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Barnes-Jewish Hospital West County | Creve Coeur | Missouri | 63141 | Beryne Odeny, M.D., MPH, Ph.D. (PRINCIPAL_INVESTIGATOR) Michelle V Lee, M.D. (SUB_INVESTIGATOR) Aren B Mntzakanian, M.S. (SUB_INVESTIGATOR) |
Find similar trials in Creve Coeur, MO
Related Studies
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid TumorsRecruiting · Washington University School of Medicine · St Louis, Missouri
- A Study of Combining Cabozantinib and Atezolizumab for Advanced/Metastatic NSCLC (Cabatezo-1)PHASE2 · Not Yet Recruiting · Jun Zhang, MD, PhD · Kansas City, Kansas
- A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 ExpressionPHASE1/PHASE2 · Recruiting · A2 Biotherapeutics Inc. · Gilbert, Arizona